TwitterLinkedin

Contact Us

  • News & Events
    • News
    • Press Releases
    • Webinars
    • Events
  • Resource Library
    • Thought Leadership
    • Fact Flyers
    • Case Studies
    • White Papers
    • Webinars
    • Infographics
    • Video & Animation
  • Careers
    • Working at PharmaLex
    • Your Application Process
    • Current Opportunities
  • Training
Top Bar
Search
PharmaLex Logo
MENUMENU
  • PharmaLex Logo
  • PharmaLex Logo
  • About UsAbout Us
    • About Us
    • Management Team
    • Our Milestones
    • Corporate Social Responsibility
    • What Our Clients Say About Us
  • Our Services
    • Discovery / Non-clinical

          • Go to Discovery / Non-clinical section >>

          • Strategy and Consulting

            • Integrated Product Development
            • Market Access
            • Scientific Advice
            • Statistical Services
    • Clinical Development

          • Go to Clinical Development section >>

          • Strategy and Consulting

            • Clinical Program Development
            • Scientific Advice
            • Statistical Services

          • Regulatory Affairs

            • Clinical Trial Applications
            • Health Authority / Agency Interaction
            • Regulatory Operations

          • Pharmacovigilance

            • Clinical Trial Safety Support

          • Quality

            • GxP Services
            • Interim / Contract QA
            • Quality Management Systems
            • Tech Transfer / Scale-up
    • Authorization / Approval

          • Go to Authorization / Approval section >>

          • Strategy and Consulting

            • Market Access

          • Regulatory Affairs

            • CMC Services
            • Health Authority / Agency Interaction
            • Marketing and Labeling Activities
            • Regulatory Operations
            • Scientific, Regulatory and Technical Writing
            • Statistical Services

          • Pharmacovigilance

            • EU QPPV / National QPPV

          • Quality

            • Commissioning, Qualification, and Validation (CQV)
            • GxP Services
            • Interim / Contract QA
    • Post-approval / Maintenance

          • Go to Post-approval / Maintenance section >>

          • Strategy and Consulting

            • Market Access

          • Regulatory Affairs

            • CMC Services
            • Global End-to-End Outsourcing
            • Health Authority / Agency Interaction
            • Marketing and Labeling Activities
            • Mergers and Acquisitions (M&A) Transfers
            • Regulatory Operations

          • Pharmacovigilance

            • EU QPPV / National QPPV
            • ICSR Management
            • Literature Monitoring & Screening
            • Pharmacovigilance Quality & Compliance
            • Signal Management

          • Quality

            • Commissioning, Qualification, and Validation (CQV)
            • Good Distribution Practice (GDP) Compliance
            • GxP Services
            • Interim / Contract QA
            • Quality Management Systems

          • Medical Affairs

            • Healthcare Compliance and Medical Approval
    • Program Management

          • Go to Program Management section >>

          • Program Management

            • Global End-to-End Outsourcing
            • Integrated Product Development
            • Mergers and Acquisitions (M&A) Transfers
    • Featured Expertise

          • Industry Expertise

            • Biopharmaceuticals
            • MedTech Services

          • Service Expertise

            • ATMP / Cell and Gene Therapy
            • Brexit
            • COVID-19 Support
            • GxP Services
            • Market Access
            • Statistical Services
            • SMARTPHLEX - technology-enabled services
  • Global ReachGlobal Reach
  • Contact usContact us
  • News & Events
    • News
    • Press Releases
    • Webinars
    • Events
  • Resource Library
    • Thought Leadership
    • Fact Flyers
    • Case Studies
    • White Papers
    • Webinars
    • Infographics
    • Video & Animation
  • Careers
    • Working at PharmaLex
    • Your Application Process
    • Career Opportunities
  • Training
Home > News & Events > News > Page 19

News

Market Authorisation Holders – Plan Ahead for Brexit

Market Authorisation Holders – Plan Ahead for Brexit

15th February 2018

Leadership Tips from Ann McGee

Leadership Tips from Ann McGee

8th February 2018

Top Tips to Avoid the Frequent FDA Form 483 Observations

Top Tips to Avoid the Frequent FDA Form 483 Observations

8th February 2018

Brexit and the Pharma Industry – January 2018 Updates

Brexit and the Pharma Industry – January 2018 Updates

31st January 2018

GDP – US and EU Deficiencies

GDP – US and EU Deficiencies

22nd January 2018

Long awaited revision of Annex 1

Long awaited revision of Annex 1

18th January 2018

The importance of Quality and Company Culture in 2018

The importance of Quality and Company Culture in 2018

9th January 2018

DIA Europe 2018

DIA Europe 2018

8th January 2018

World Drug Safety Congress Americas 2018

World Drug Safety Congress Americas 2018

5th January 2018

DIA RSIDM Forum

DIA RSIDM Forum

5th January 2018

DIA 2018 – PV and Risk Management Strategies Conference

DIA 2018 – PV and Risk Management Strategies Conference

21st December 2017

EMA to relocate to Amsterdam

EMA to relocate to Amsterdam

23rd November 2017
1
2345678910111213141516
…171819202122
prevnext
Upcoming Webinars

September 14th, 2021

TOPRA event Webinar: Nitrosamine Risk Assessment for New MAAs’

Upcoming Events

September 14th, 2021

TOPRA event Webinar: Nitrosamine Risk Assessment for New MAAs’

September 22 - 24th, 2021

TOPRA Symposium 2021

Categories
  • All News
  • Webinars
  • Events
Archive
USEFUL LINKS
  • Home
  • Contact us
  • Imprint
  • Data Protection
  • Terms and Conditions
RECENT TWEETS
Tweets by @PharmaLexGLOBAL
COVID-19 NEWSLETTER SIGN UP

SIGN UP NOW

WHAT OUR CLIENTS SAY

  • What was especially important to me was their ability to get a team, with the right experience, together so quickly.

    Mid-size Biotech
    Head of Outsourcing
PharmaLex
©2021 PharmaLex GmbH. All rights reserved.

ISO9001:2015 LogoEnergie Audit Logo

    Please DO NOT send us event/conference information.
    We will not respond and these will be deleted immediately.





    Select your state:

    .
    You can unsubscribe at any time at data.protection@pharmalex.com

    Click here to view our Privacy Policy.

    #AskTheExpert #TogetherBEYONDCOVID19





      Select your state:

      .
      You can unsubscribe at any time at data.protection@pharmalex.com

      If you do not wish to receive any communication from us, you can unsubscribe at any time at. Click here to view our Privacy Policy.

      #TogetherBEYONDCOVID19

      We closely monitor developments and updates surrounding the current outbreak of Coronavirus Disease 2019 (COVID-19) from official sources including the World Health Organisation and are following the guidance and direction of the governments and the local authorities. We are taking this situation very seriously and our number one priority is the safety and business continuity for our customers and colleagues. As ever, we will do everything we can to ensure that services are delivered within the required time and the trusted quality PharmaLex is known for